摘要
在全世界,脑血管病是第1位的致残原因和第2位的致死原因。其中蛛网膜下腔出血(SAH)占脑血管疾病的6%~8%,而脑血管痉挛(CVS)是SAH后最严重的并发症之一,是致死和重残的主要因素。虽然目前SAH后CVS病理生理学机制研究和治疗方案方面已有所进展,但对SAH后的CVS及其引起的迟发性脑缺血痉挛尚无确切的预防和治疗方法,因此,积极预防和治疗SAH后CVS具有十分重要的意义。
Cerebrovascular disease is the first reason to cause mutilation and the second reason to induce death all over the world. Subarachnoid hemorrhage (SAH)accounts for about 6% - 8% of cerebrovascular disease. Cerebral vasospasm(CVS) is one of the most severe concurrent disease of SAH and is the main reason to cause mutilation and death. Although there are many research progresses in the pathophysiology mechanism and therapeutic regimen ,there is not any exact prevention and therapy method to treat CVS and DCVS after SAH. Therefore there are of great significance to prevent and treat CVS after SAH.
出处
《医学综述》
2009年第11期1659-1662,共4页
Medical Recapitulate
关键词
脑血管痉挛
蛛网膜下腔出血
黏附分子
Cerebral vasospasm
Subarachnoid hemorrhage
Adhesion molecule